TransMedics Group Inc (TMDX)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | -26,728 | -36,065 | -59,279 | -28,748 | -33,547 |
Revenue | US$ in thousands | 241,623 | 93,459 | 30,262 | 25,639 | 23,604 |
Pretax margin | -11.06% | -38.59% | -195.89% | -112.13% | -142.12% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-26,728K ÷ $241,623K
= -11.06%
TransMedics Group Inc's pretax margin has shown a significant improvement over the past five years. The company experienced negative pretax margins in each of these years, indicating that its operating expenses and costs exceeded its revenues. However, the trend has been gradually improving, as seen from the narrowing of the pretax margin from -142.12% in 2019 to -11.06% in 2023. This suggests that the company has been able to better control its costs and expenses relative to its revenues over time. While the pretax margin is still negative, the decreasing trend indicates a positive direction for TransMedics Group Inc in terms of potential profitability and efficiency in managing its operations.
Peer comparison
Dec 31, 2023